My name is Christopher Carlin and I am a recent graduate of the Master of Microbial Biotechnology degree program at North Carolina State University. Prior to joining the program, I earned a Bachelor of Arts degree in Biology and gained work experience in infectious disease diagnostics and therapeutics in the greater Boston area. I seek to leverage my graduate and work experiences to transition into life sciences product management.
Christopher Carlin
Professional Science Master's > Microbial Biotechnology
Bachelor of Arts > Biology
​
Email:
carlin.christopher@gmail.com
​
LinkedIn:
www.linkedin.com/in/cscarlin
​
EDUCATION
2017-2019
Professional Science Master's
Microbial Biotechnology
2005-2009
Bachelor of Arts
Biology
North Carolina State University
Raleigh, NC
Bowdoin College
Brunswick, ME
SCIENTIFIC EXPERIENCE
Industry
June 2018 - August 2018
Indigo Agriculture (RTP, NC)
Microbial Resources Intern
​
​
August 2012 - September 2016
OpGen, Inc. (Woburn, MA)
Scientist I
​
​​
Research
September 2009 - August 2012
Ragon Institute of MGH, MIT
and Harvard (Cambridge, MA)
Principal Investigator: Dr. Sylvie Le Gall​
June 2008 - May 2009
Bowdoin College (Brunswick, ME)
Biology Department
Research Advisor: Dr. Anne McBride
Executed collection of stability data for key microbiological assets and advised on expansion of molecular biology processes
Developed Class I and II in vitro diagnostic medical devices using Peptide Nucleic Acid Fluorescent in situ Hybridization (PNA FISH) technology
Investigated the effects of HIV-1 infection and cellular activation on host protein expression
Thesis: Investigation of a Putative Arginine Demethylase in the Opportunistic Commensal Candida albicans
Undergraduate Coursework
​
-
General Biology
-
Biochemistry & Cell Biology
-
Developmental Biology
-
Ecology and Conservation
-
Epidemiology
-
Evolution
-
Food Microbiology
-
Immunology
-
Microbiology
-
Molecular Evolution
-
Advanced Genetics and Epigenetics
-
Advanced Independent Study (2 semesters)
-
General Chemistry
-
Organic Chemistry I
-
Physics I
Virus Biotechnology
Graduate Coursework
-
Industrial Case Studies in Microbial Biotechnology (4 semesters)
-
Microbial Metabolic Regulation
-
Systems Biology Modeling of Plant Regulation
-
Virus Biotechnology: Pathogens to Therapeutics
-
Real-time PCR Techniques
-
Gene Manipulation in Zebrafish
-
Confocal Microscopy
-
Statistical Methods for Researchers I
-
Current Topics in BioScience Management
-
Legal & Market Dynamics in Pharmaceutical and Biotechnology Commerce
-
Special Topics in Business Management: Value Creation Practicum
Host Cell Infectivity
Frog Virus 3 ORF19R
Real-time PCR Techniques
AHR1A & HSP90AB1
Research Proposal
Gene Manipulation
Tol2 Transposase
CRISPR-Cas9
Confocal Microscopy
Final Image Portfolio
CAREER OBJECTIVES
Scientist at a small- to medium-sized biotechnology company
Project Manager at a small- to medium-sized biotechnology company
Product Manager at a small- to medium-sized biotechnology company
PRACTICUM PROJECTS
Left to Right: Chika Nwugo, Esteban Niaves, Carly Elkins, Swetha Srinivasan, Ryan Overcash, Christopher Carlin, and Zachary Jernigan
Spring 2018
The team performed market research on the agricultural pest management market to address the opportunity for a combination synthetic and biological pesticide product. Data were collected from pesticide labels, patent searches, and a survey of farmers, academics, and regulatory professionals.
Left to Right: Matt Thompson, Abigail Nails, Grace Carrell, Jennifer Massengill, Kristine Newman, Leslie Shannon, and Christopher Carlin
Fall 2017
The team was tasked with a business development case to identify commercialization strategies for diagnostic oncology data. Market players, pricing structures, and existing data partnerships were evaluated through voice of the customer and secondary research.
Left to Right: Rivers Baker, Esteban Niaves, Tony Liu,
Briggs Hagler, Stephen Yang, and Christopher Carlin
Fall 2018
The team investigated consumer segments within the dietary fats and oils market to provide insights related to the current growth in the sales of interesterification enzymes. Identity, processing, and functionality characteristics were examined and connected through blogs, product portfolios, scientific literature, and interviews with industry experts.
COMMUNICATION & TEAMWORK
Multiplex Blood Culture Test team (circa 2013). While at AdvanDx, Inc. (now OpGen, Inc.), I participated in the feasibility phase of this project from 2013-2016 and was responsible for the development of three Gram-negative assays and the sample preparation buffer.
Left to Right: Adam McDermott, Christopher Carlin, Linta Rahman, and Michelle Meltzer
CMI Project Fall 2017
CMI Project Fall 2018
Literature Review (Fall 2017) - Liquid Biopsy
Literature Review (Spring 2018) - Phage Therapy
Literature Review (Fall 2018) - LRTI Diagnostic
All Videos
Biotech Company Presentation - NanoVector, Inc.